Targeted treatment of acute myeloid leukemia in older adults: role of gemtuzumab ozogamicin.
about
Innovative proteomics for the discovery of systemically accessible cancer biomarkers suitable for imaging and targeted therapiesTarget Therapy in Hematological Malignances: New Monoclonal Antibodies.Immunotherapy with histamine dihydrochloride for the prevention of relapse in acute myeloid leukemia.The complete 12 Mb genome and transcriptome of Nonomuraea gerenzanensis with new insights into its duplicated "magic" RNA polymerase.Immune responses and long-term disease recurrence status after telomerase-based dendritic cell immunotherapy in patients with acute myeloid leukemia.Identifying biomarkers of breast cancer micrometastatic disease in bone marrow using a patient-derived xenograft mouse model.
P2860
Targeted treatment of acute myeloid leukemia in older adults: role of gemtuzumab ozogamicin.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 14 May 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Targeted treatment of acute my ...... role of gemtuzumab ozogamicin.
@en
Targeted treatment of acute my ...... role of gemtuzumab ozogamicin.
@nl
type
label
Targeted treatment of acute my ...... role of gemtuzumab ozogamicin.
@en
Targeted treatment of acute my ...... role of gemtuzumab ozogamicin.
@nl
prefLabel
Targeted treatment of acute my ...... role of gemtuzumab ozogamicin.
@en
Targeted treatment of acute my ...... role of gemtuzumab ozogamicin.
@nl
P2860
P921
P356
P1476
Targeted treatment of acute my ...... role of gemtuzumab ozogamicin.
@en
P2093
Hien K Duong
Mikkael A Sekeres
P2860
P304
P356
10.2147/CIA.S3968
P407
P577
2009-05-14T00:00:00Z